Showing results (31-40 of 97) with videos related to
Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2012
Gene modules and response to neoadjuvant chemotherapy in breast cancer subtypes: a pooled analysisMichail Ignatiadis, Sandeep K Singhal, Christine Desmedt, et al.Lung Cancer (Amsterdam, Netherlands)|July 5, 2005
Front-line treatment of advanced non-small cell lung cancer with irinotecan and docetaxel: a multicentre phase II studyPanagiotis Ziotopoulos, Nikolaos Androulakis, Efthimia Mylonaki, et al.Cancer Treatment Reviews|May 7, 2013
Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancerKamal S Saini, Sherene Loi, Evandro de Azambuja, et al.Clinical Lung Cancer|December 16, 2005
Sequential versus alternating administration of cisplatin/etoposide and topotecan as first-line treatment in extensive-stage small-cell lung cancer: preliminary results of a Phase III Trial of the Hellenic Oncology Research GroupMichail Ignatiadis, Dimitris Mavroudis, Marinos Veslemes, et al.NPJ Breast Cancer|July 5, 2022
Interrogating breast cancer heterogeneity using single and pooled circulating tumor cell analysisFrançoise Rothé, David Venet, Dieter Peeters, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancerNikolaos Xenidis, Michail Ignatiadis, Stella Apostolaki, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2012
Elucidating prognosis and biology of breast cancer arising in young women using gene expression profilingHatem A Azim, Stefan Michiels, Philippe L Bedard, et al.Anticancer Research|January 12, 2007
Post-operative combined radiation and chemotherapy with temozolomide and irinotecan in patients with high-grade astrocytic tumors. A phase II study with biomarker evaluationGeorge Fountzilas, George Karkavelas, Anna Kalogera-Fountzila, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 24, 2007
Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancerMichail Ignatiadis, Nikos Xenidis, Maria Perraki, et al.Plos One|July 9, 2011
Global microRNA expression profiling identifies MiR-210 associated with tumor proliferation, invasion and poor clinical outcome in breast cancerFrançoise Rothé, Michail Ignatiadis, Carole Chaboteaux, et al.Pageof 10